Clinical Trial Update: Vaginal Isonicotinic Acid Hydrazide (INH) Administration Prior to T380A Intrauterine Device Insertion [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating vaginal INH administration before T380A intrauterine device insertion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Device-related Complications
• Uterine Gynecologic Conditions

Drugs mentioned

• T380A intrauterine device (intrauterine device (T380A))
• Vaginal Isonicotinic Acid Hydrazide (INH) (isonicotinic acid hydrazide)

Snippet

Sponsor: Aswan University Hospital | Conditions: IUCD Complication | Phase 4 | Status: COMPLETED